Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-24-014484
Filing Date
2024-04-12
Accepted
2024-04-12 17:15:49
Documents
82

Document Format Files

Seq Description Document Type Size
1 formposam.htm   iXBRL POS AM 3343974
2 ex5-1.htm EX-5.1 9824
3 ex23-1.htm EX-23.1 6453
4 ex107.htm EX-FILING FEES 10859
5 ex5-1_001.jpg GRAPHIC 4365
  Complete submission text file 0001493152-24-014484.txt   11482643

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20231231.xsd EX-101.SCH 87373
7 XBRL CALCULATION FILE otlc-20231231_cal.xml EX-101.CAL 59956
8 XBRL DEFINITION FILE otlc-20231231_def.xml EX-101.DEF 378267
9 XBRL LABEL FILE otlc-20231231_lab.xml EX-101.LAB 528329
10 XBRL PRESENTATION FILE otlc-20231231_pre.xml EX-101.PRE 455804
86 EXTRACTED XBRL INSTANCE DOCUMENT formposam_htm.xml XML 1696822
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-256448 | Film No.: 24842374
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)